←
Pharmaceutical Executive26,128 posts
Pharmaceutical Executive avatar

Pharmaceutical Executive

@PharmExec

Official Twitter account for Pharmaceutical Executive, a digital and print magazine offering news and opinions, analysis, features and executive profiles.

◷ Joined February 2009▧ 3,820 Photos and videos
Pharmaceutical Executive avatar
Pharmaceutical Executive@PharmExec·14 Mar 2025

🚨Our March issue is LIVE🚨 Learn about immunotherapy pioneer Mark Frohlich, MD, CEO of Indapta Therapeutics in our cover profile🔷 Sourcing, nurturing, and retaining talent🔷Making HCP analytics actually work for commercial teams🔷and much more right here➡️pharmexec.com/journals/pharm…

Post attachment
Pharmaceutical Executive avatar
Pharmaceutical Executive@PharmExec·2h

CGT success is often limited not by the science, but by execution. Cencora’s Louis Cicchini on the early, cross-functional decisions that keep launches on track. 🔗 Read where siloed planning creates barriers: hubs.li/Q04DjG3f0 #Pharma

Post attachment
Pharmaceutical Executive avatar
Pharmaceutical Executive@PharmExec·Nov 13

7,000+ state legislative seats and 36 governorships were on the ballot this cycle, and drug pricing policy is following the results. PhRMA’s Scott LaGanga tells Pharm Exec’s Mike Christel why PBM reform is a state fight now. 🎧 Listen: hubs.li/Q04Fhhkt0 #PharmExec

1:04
Pharmaceutical Executive avatar
Pharmaceutical Executive@PharmExec·Nov 10

A tumor you treated six months ago may not be the tumor you’re treating today. Dr. Brian Corgiat senior clinical research scientist at Ignite Proteomics says testing needs to catch up to the tumor as it is now, not as it was at diagnosis. See the full interview ➡️ hubs.li/Q04DWynl0 #Oncology #PrecisionMedicine

1:11
Pharmaceutical Executive avatar
Pharmaceutical Executive@PharmExec·Nov 6

It used to be enough for manufacturing to stay off the critical path. Not anymore. Dave Maraldo, PhD (Merck) says the real unlock is bringing manufacturing into development analytics earlier, not just at handoff. 📽 Watch it here: hubs.li/Q04DCLxr0 #PharmaManufacturing #CMC

1:03
Pharmaceutical Executive avatar
Pharmaceutical Executive@PharmExec·Nov 5

Nearly 80% of approved pharma content sees little or no use by field teams. Nataliya Andreychuk, Co-founder & CEO of Viseven, explains why the edge is shifting from production capacity to decision quality. 🔗 See what content intelligence changes: hubs.li/Q04DqZqR0 #Pharma

Post attachment
Pharmaceutical Executive avatar
Pharmaceutical Executive@PharmExec·Nov 4

State lawmakers are becoming the biggest force in drug pricing, moving faster than Washington. PhRMA’s Scott LaGanga joins Pharm Exec’s Mike Christel to talk PBM reform, with 7,000+ state seats on the ballot this cycle. 🎧 Listen: hubs.li/Q04DmRrw0 #PharmExec

Post attachment